Morgan Stanley upgraded Takeda (TAK) to Overweight from Equal Weight with a price target of 5,500 yen, up from 4,300 yen. The company does not ...
News we're reading • Sheriff bought soft-serve ice cream machines for jail employees (story includes correction) (padailypost ...
Mirum Pharmaceuticals (MIRM) announced that its partner, Takeda (TAK), has received approval by the Japanese Ministry of Health, Labour, and ...
WITHit ( the leader in innovative wearable tech accessories, is welcoming spring with a bold new collection of Apple Watch bands and cases. Designed for comfort and versatility, these accessories ...
Thermo Fisher Scientific Inc., the world leader in serving science, has announced a Technology Alliance Agreement with the Chan Zuckerberg Institute for Advanced Biological Imaging (CZ Imaging ...
LIVMARLI is the first and only treatment available for cholestatic pruritus in patients with Alagille syndrome and ...
Mirum Pharmaceuticals stock surged 25% and how LIVMARLI drives growth. Explore future prospects with Volixibat. Click here to ...
Mirum Pharmaceuticals, Inc. shows strong growth with a 43% revenue jump and promising pipeline assets. Click here for my ...
Zacks Investment Research on MSN13d
Mirum's Heavy Dependence on Livmarli for Revenues Remains a WoeMirum Pharmaceuticals’ MIRM lead product, Livmarli (maralixibat), an orally administered ileal bile acid transporter (“IBAT”) ...
Raymond James Financial Inc. bought a new stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) during the 4th quarter, according to the company in its most recent disclosure with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback